{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:19:52Z","timestamp":1776723592260,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Research Project of Education Department of Jiangxi Province","award":["GJJ2200121"],"award-info":[{"award-number":["GJJ2200121"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hashimoto's thyroiditis (HT) is a common benign thyroid disease that often coexists with papillary thyroid carcinoma (PTC). Owing to the diffuse changes in the thyroid caused by HT, PTCs can be challenging to detect using conventional imaging modalities such as ultrasound and CT. The aim of this study was to develop a radiomics model based on nonenhanced CT (NECT) to predict the presence of PTC in the patients with HT, thereby improving early diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective study included pathologically confirmed HT patients with or without PTC who underwent NECT scans within 30 days before surgery from January 2017 to April 2023 at Hospital I and Hospital II. The patients from hospital I were divided randomly at a ratio of 8:2 into a training cohort and an internal validation cohort. The patients from hospital II were assigned to the external validation cohort. Radiomic features were extracted using PyRadiomics. Intraclass correlation coefficient, Pearson correlation and LASSO analyses were conducted to reduce the dimensionality of the radiomic features. Four machine learning algorithms, including logistic regression (LR), naive bayes (NB), support vector machine (SVM), and multilayer perceptron (MLP) classifiers, were employed to develop and validate the prediction models based on the remaining features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 130 patients, 89 from Hospital I [71 in the training cohort and 18 internal validation cohort] and 41 from Hospital II [external validation cohort], were included. Six features with nonzero coefficients were retained by the LASSO algorithm for inclusion in the machine learning models. In the external validation cohort, the LR, NB, SVM, and MLP models obtained AUCs of 0.736, 0.690, 0.751 and 0.783, respectively. The MLP model performed the best in the external validation cohort, with an area under the curve of 0.783, a sensitivity of 0.643, and a specificity of 0.923.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A radiomics model based on NECT could identify PTCs in patients with HT and had the potential to enhance early diagnosis and intervention for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15206-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:07Z","timestamp":1762962187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonenhanced CT-Based radiomics model enhances PTC detection in Hashimoto\u2019s thyroiditis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yun","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianggeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"10","key":"15206_CR1","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A. Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649.","journal-title":"Autoimmun Rev"},{"key":"15206_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801925","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y, et al. Hashimoto\u2019s thyroiditis: a double-edged sword in thyroid carcinoma. Front Endocrinol (Lausanne). 2022;13:801925.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"15206_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18526","volume":"4","author":"S Xu","year":"2021","unstructured":"Xu S, Huang H, Qian J, Liu Y, Huang Y, Wang X, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Netw Open. 2021;4(7):e2118526.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"15206_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bjorl.2017.08.012","volume":"84","author":"B Uhliarova","year":"2018","unstructured":"Uhliarova B, Hajtman A. Hashimoto\u2019s thyroiditis - an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol. 2018;84(6):729\u201335.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"4","key":"15206_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12022-018-9540-9","volume":"29","author":"D Lubin","year":"2018","unstructured":"Lubin D, Baraban E, Lisby A, Jalali-Farahani S, Zhang P, Livolsi V. Papillary thyroid carcinoma emerging from Hashimoto thyroiditis demonstrates increased PD-L1 expression, which persists with metastasis. Endocr Pathol. 2018;29(4):317\u201323.","journal-title":"Endocr Pathol"},{"issue":"12","key":"15206_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","volume":"25","author":"M Ehlers","year":"2014","unstructured":"Ehlers M, Schott M. Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab. 2014;25(12):656\u201364.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"15206_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14740\/wjon1728","volume":"15","author":"H Vargas-Uricoechea","year":"2024","unstructured":"Vargas-Uricoechea H. Autoimmune thyroid disease and differentiated thyroid carcinoma: a review of the mechanisms that explain an intriguing and exciting relationship. World J Oncol. 2024;15(1):14\u201327.","journal-title":"World J Oncol"},{"key":"15206_CR8","doi-asserted-by":"publisher","unstructured":"Zolotov S: GeneticTesting in Differentiated Thyroid Carcinoma: Indications and Clinical Implications. RambamMaimonides Med J. 2016;7(1):e0009.\u00a0https:\/\/doi.org\/10.5041\/RMMJ.10236.","DOI":"10.5041\/RMMJ.10236"},{"issue":"4","key":"15206_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.clinimag.2012.12.005","volume":"37","author":"ZJ Han","year":"2013","unstructured":"Han ZJ, Shu YY, Lai XF, Chen WH. Value of computed tomography in determining the nature of papillary thyroid microcarcinomas: evaluation of the computed tomographic characteristics. Clin Imaging. 2013;37(4):664\u20138.","journal-title":"Clin Imaging"},{"issue":"18","key":"15206_CR10","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157\u201364.","journal-title":"J Clin Oncol"},{"issue":"1","key":"15206_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15027-z","volume":"11","author":"X Zheng","year":"2020","unstructured":"Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11(1):1236.","journal-title":"Nat Commun"},{"key":"15206_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1267886","volume":"14","author":"M Fang","year":"2023","unstructured":"Fang M, Lei M, Chen X, Cao H, Duan X, Yuan H, et al. Radiomics-based ultrasound models for thyroid nodule differentiation in Hashimoto\u2019s thyroiditis. Front Endocrinol (Lausanne). 2023;14:1267886.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"15206_CR13","doi-asserted-by":"publisher","first-page":"565000","DOI":"10.3389\/fendo.2020.565000","volume":"11","author":"C Offi","year":"2020","unstructured":"Offi C, Garberoglio S, Antonelli G, Esposito MG, Brancaccio U, Misso C, D\u2019Ambrosio E, Pace D, Spiezia S. The ablation of thyroid nodule\u2019s afferent arteries before radiofrequency ablation: preliminary data. Front Endocrinol (Lausanne). 2020;11:565000.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"15206_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6328329","volume":"2019","author":"B Colakoglu","year":"2019","unstructured":"Colakoglu B, Alis D, Yergin M. Diagnostic value of machine learning-based quantitative texture analysis in differentiating benign and malignant thyroid nodules. J Oncol. 2019;2019:6328329.","journal-title":"J Oncol"},{"issue":"7","key":"15206_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.acra.2022.09.002","volume":"30","author":"Y Peng","year":"2023","unstructured":"Peng Y, Zhang ZT, Wang TT, Wang Y, Li CH, Zuo MJ, et al. Prediction of central lymph node metastasis in cN0 papillary thyroid carcinoma by CT radiomics. Acad Radiol. 2023;30(7):1400\u20137.","journal-title":"Acad Radiol"},{"key":"15206_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108755","volume":"122","author":"H Wang","year":"2020","unstructured":"Wang H, Song B, Ye N, Ren J, Sun X, Dai Z, et al. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma. Eur J Radiol. 2020;122:108755.","journal-title":"Eur J Radiol"},{"key":"15206_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.580886","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li J, Mou Y, Yao Y, Cui J, Mao N, et al. Radiomics nomogram for identifying sub-1 cm benign and malignant thyroid lesions. Front Oncol. 2021;11:580886.","journal-title":"Front Oncol"},{"issue":"2","key":"15206_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.14366\/usg.22111","volume":"42","author":"H Seo","year":"2023","unstructured":"Seo H, Jin KN, Park JS, Kang KM, Lee EK, Lee JY, et al. Risk of thyroid cancer in a lung cancer screening population of the National Lung Screening Trial according to the presence of incidental thyroid nodules detected on low-dose chest CT. Ultrasonography. 2023;42(2):275\u201385.","journal-title":"Ultrasonography"},{"key":"15206_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2024.110162","volume":"110","author":"M van Gerwen","year":"2024","unstructured":"van Gerwen M, Ma T, Yip R, Choi C, Paksashvili N, Yankelevitz D, et al. Thyroid abnormalities identified on CT screening for lung cancer. Clin Imaging. 2024;110:110162.","journal-title":"Clin Imaging"},{"issue":"5","key":"15206_CR20","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/j.chest.2021.06.063","volume":"160","author":"PJ Mazzone","year":"2021","unstructured":"Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2021;160(5):e427-94.","journal-title":"Chest"},{"key":"15206_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2021.106609","volume":"215","author":"A Abbasian Ardakani","year":"2022","unstructured":"Abbasian Ardakani A, Bureau NJ, Ciaccio EJ, Acharya UR. Interpretation of radiomics features-a pictorial review. Comput Methods Programs Biomed. 2022;215:106609.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"15206_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06433-7","volume":"24","author":"Q Ye","year":"2023","unstructured":"Ye Q, He D, Ding X, Wang Y, Wei Y, Liu J. Quantitative evaluation of the infrapatellar fat pad in knee osteoarthritis: MRI-based radiomic signature. BMC Musculoskelet Disord. 2023;24(1):326.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"15206_CR23","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1007\/s00330-024-10786-5","volume":"34","author":"Y Fu","year":"2024","unstructured":"Fu Y, Lei YT, Huang YH, Mei F, Wang S, Yan K, et al. Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study. Eur Radiol. 2024;34(11):7080\u20139.","journal-title":"Eur Radiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15206-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:07Z","timestamp":1762962187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15206-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15206"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15206-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4862440\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedural aspects of this investigation were conducted in accordance with the 2013 revision of the Declaration of Helsinki. Ethical approval was granted by the Second Affiliated Hospital of Nanchang University Medical Research Ethics Committee, which waived the requirement for informed consent because the study was retrospective and relied solely on fully anonymised data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1760"}}